New York State Common Retirement Fund’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY.RT
PCM
LCM
FCM
ACM
CS
New York State Common Retirement Fund's BMY.RT Position: Q1 2020 in Review
New York State Common Retirement Fund sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2020, closing a stake of 525,881 shares — an estimated $1.58M sold.
New York State Common Retirement Fund first reported a position in BMY.RT in Q4 2019 and held it in 1 quarter. The position peaked at $1.58M in Q4 2019. 581 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2020.
- New York State Common Retirement Fund reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- New York State Common Retirement Fund sold 525,881 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2020, an estimated $1.58M.
- New York State Common Retirement Fund first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 1 quarter.
- New York State Common Retirement Fund's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.58M in Q4 2019.
- 581 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2020.
Based on New York State Common Retirement Fund's 13F filing for Q1 2020, filed 6 May 2020.